1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

2.           North America Immunochemistry Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Immunochemistry Market – Market Landscape

4.1         Overview

4.2         Market Segmentation

4.2.1        North America Immunochemistry Market – By Product

4.2.2        North America Immunochemistry Market – By Application

4.2.3        North America Immunochemistry Market – By End User

4.2.4        North America Immunochemistry Market – By Country

4.3         PEST Analysis

5.           North America Immunochemistry Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Incidences of Chronic and Infectious Diseases

5.1.2        Increasing Geriatric Population

5.2         Key Market Restraints

5.2.1        Limitations Associated with Immunohistochemistry

5.3         Key Market Opportunities

5.3.1        Development Opportunities in Emerging Countries

5.4         Future Trends

5.4.1        Increasing Acceptance of Automation in Immunohistochemistry

5.5         Impact Analysis

6.           Immunochemistry Market – North America Analysis

6.1         North America Immunochemistry Market Revenue Forecasts And Analysis

6.2         Performance of Key Players

7.           North America Immunochemistry Market Analysis – By Application

7.1         Overview

7.2         North America Immunochemistry Market, By Application, 2018 & 2027 (%)

7.3         North America Immunochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

7.4         Diagnostics

7.4.1        Overview

7.4.2        North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3        Cancer

7.4.3.1          Overview

7.4.3.2          North America Cancer Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Infectious Diseases

7.4.4.1          Overview

7.4.4.2          North America Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5        Autoimmune Diseases

7.4.5.1          Overview

7.4.5.2          North America Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.4.6        Nephrological Diseases

7.4.6.1          Overview

7.4.6.2          North America Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Drug Testing

7.5.1        Overview

7.5.2        North America Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America Immunochemistry Market Analysis – By Product

8.1         Overview

8.2         North America Immunochemistry Market, By Product, 2018 & 2027 (%)

8.3         North America Immunochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1        North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2        North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2.1          North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4         Antibodies Market

8.4.1        Overview

8.4.2        North America Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.3        Primary Antibodies

8.4.3.1          Overview

8.4.3.2          North America Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4        Secondary Antibodies

8.4.4.1          Overview

8.4.4.2          North America Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Equipment

8.5.1        Overview

8.5.2        North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.3        Slide Staining Systems

8.5.3.1          Overview

8.5.3.2          North America Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4        Tissue Microarrays

8.5.4.1          Overview

8.5.4.2          North America Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.5        Slide Scanners

8.5.5.1          Overview

8.5.5.2          North America Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.6        Other Equipment

8.5.6.1          Overview

8.5.6.2          North America Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Reagents

8.6.1        Overview

8.6.2        North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.3        Histological Stains

8.6.3.1          Overview

8.6.3.2          North America Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.4        Blocking & Fixation Reagents

8.6.4.1          Overview

8.6.4.2          North America Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.5        Chromogenic Substrates

8.6.5.1          Overview

8.6.5.2          North America Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.6        Stabilizers

8.6.6.1          Overview

8.6.6.2          North America Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.7        Proteolytic Enzymes

8.6.7.1          Overview

8.6.7.2          North America Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.8        Solvents

8.6.8.1          Overview

8.6.8.2          North America Solvents Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Kits

8.7.1        Overview

8.7.2        North America Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9.           North America Immunochemistry Market Analysis – By End User

9.1         Overview

9.2         North America Immunochemistry Market, By End User, 2018 & 2027 (%)

9.3         North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4         Hospital & Diagnostic Laboratories

9.4.1        Overview

9.4.2        North America Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Research Institutes

9.5.1        Overview

9.5.2        North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

9.6         Others End Users

9.6.1        Overview

9.6.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.        North America Immunochemistry Market Revenue and Forecasts To 2027

10.1      Overview

10.1.1     North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.2.1       North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3.1       North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.2       North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.3       North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5     North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.1.6     US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1       US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2       US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.6.2.1       US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3       US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3.1       US Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.2       US Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.3       US Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.4       US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7     Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1       Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2       Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.7.2.1       Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3       Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3.1       Canada Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.2       Canada Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.3       Canada Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.4       Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1       Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2       Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.8.2.1       Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3       Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3.1       Mexico Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.2       Mexico Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.3       Mexico Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.4       Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.        Immunochemistry Market – Industry Landscape

11.1      Overview

11.2      Growth Strategies done by the companies in the Market, 2018 (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic developments

11.4.1     Overview

12.        Immunohistochemistry Market – Key Company Profiles

12.1      Bio SB

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product portfolio

12.1.5     SWOT ANALYSIS

12.1.6     Key Developments

12.2      Cell Signaling Technology, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product portfolio

12.2.5     SWOT ANALYSIS

12.2.6     Key Developments

12.3      F. Hoffmann-La Roche Ltd.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Merck KGaA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      PerkinElmer, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Thermo Fisher Scientific, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Overview

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Abcam Plc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Agilent Technologies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Bio-Rad Laboratories, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Information

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Danaher

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Financial Information

12.10.4  Product Portfolio

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary Of Terms

13.3      Methodology

13.3.1     Coverage

13.3.2     Secondary Research

13.3.3     Primary Research

LIST OF TABLES

Table 1.          North America Immunochemistry Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 2.          North America Immunochemistry Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3.          North America Antibodies Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.          North America Equipment Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 5.          North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 6.          North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7.          North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 8.          North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 9.          North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 10.         North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 12.         North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 13.         North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 14.         US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 15.         US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 16.         US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 17.         US Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 18.         US Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 19.         US Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.         US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 22.         Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 23.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 24.         Canada Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 25.         Canada Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 26.         Canada Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 27.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 28.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 29.         Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 30.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 31.         Mexico Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 32.         Mexico Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 33.         Mexico Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 34.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 35.         Organic Developments Done By Companies

Table 36.         Inorganic developments done by Companies

Table 37.         Glossary Of Terms, Immunochemistry Market

LIST OF FIGURES

Figure 1.        North America Immunochemistry Market Overview

Figure 2.        Diagnostics Segment Held Largest Share Of Application Segment In Immunochemistry Market

Figure 3.        US is Expected To Show Remarkable Growth During The Forecast Period

Figure 4.        North America Immunochemistry Market- Leading Country Markets (US$ Mn)

Figure 5.        Immunochemistry Market Segmentation

Figure 6.        North America PEST Analysis

Figure 7.        Immunochemistry Market Impact Analysis of Drivers & Restraints

Figure 8.        North America Immunochemistry Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.        Prominent Players in the Immunohistochemistry Market

Figure 10.       North America Immunochemistry Market, By Application, 2018 & 2027 (%)

Figure 11.       North America Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       North America Cancer Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       North America Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       North America Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       North America Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Immunochemistry Market, By Product 2018 & 2027 (%)

Figure 18.       North America Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       North America Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       North America Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       North America Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       North America Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       North America Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.       North America Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       North America Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       North America Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       North America Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.       North America Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       North America Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       North America Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       North America Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.       North America Solvents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       North America Kits Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       North America Immunochemistry Market, By End User, 2018 & 2027 (%)

Figure 35.       North America Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.       North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       North America Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn)

Figure 39.       North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 41.       US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.       Growth Strategies done by the companies in the Market, 2018 (%)